SCHEMBL1034404

SCHEMBL1034404

COc1cc(-c2ccnc(NC3CCCCC3)n2)ccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 5/20 0.51
CCNB1 P14635 5/20 0.51
CDK4 P11802 4/20 0.51
CCNA2 P20248 3/20 0.51
CCND1 P24385 3/20 0.51
CDK2 P24941 3/20 0.51
CCNA1 P78396 3/20 0.51
GSK3B P49841 2/20 0.51
EIF2AK2 P19525 2/20 0.51
CCNB2 O95067 2/20 0.49
CCNB3 Q8WWL7 2/20 0.49
CDC7 O00311 1/20 0.49
PLK4 O00444 1/20 0.49
JAK2 O60674 1/20 0.49
MAP4K4 O95819 1/20 0.49
INSR P06213 1/20 0.49
CSF1R P07333 1/20 0.49
PIM1 P11309 1/20 0.49
PRKACA P17612 1/20 0.49
FLT1 P17948 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1033674 0.83 CDK1 (0.57) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1033097 0.83 MKNK1 (0.57) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1034547 0.82 EIF2AK2 (0.58) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1029097 0.81 ALDH1A1 (0.55) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL2389822 0.79 IKBKB (0.55) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1029414 0.77 CDK1 (0.51) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL3648299 0.77 MAPK10 (0.60) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1033923 0.76 IKBKB (0.59) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1031885 0.76 CDK1 (0.52) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1033626 0.76 CDK1 (0.53) CDK1CCNB1CDK4CCNA2CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed